GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kindred Healthcare Inc (NYSE:KND) » Definitions » YoY EBITDA Growth

Kindred Healthcare (Kindred Healthcare) YoY EBITDA Growth : 9.59% (As of Mar. 2018)


View and export this data going back to 2001. Start your Free Trial

What is Kindred Healthcare YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Kindred Healthcare's YoY EBITDA Growth for the quarter that ended in Mar. 2018 was 9.59%.

Kindred Healthcare's EBITDA per Share for the three months ended in Mar. 2018 was $1.28.


Kindred Healthcare YoY EBITDA Growth Historical Data

The historical data trend for Kindred Healthcare's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindred Healthcare YoY EBITDA Growth Chart

Kindred Healthcare Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.45 24.81 -47.00 -57.84 -140.96

Kindred Healthcare Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.03 -122.98 125.07 -290.59 9.59

Kindred Healthcare YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Kindred Healthcare's YoY EBITDA Growth for the fiscal year that ended in Dec. 2017 is calculated as:

YoY EBITDA Growth (A: Dec. 2017 )
=(EBITDA per Share (A: Dec. 2017 )-EBITDA per Share (A: Dec. 2016 ))/ | EBITDA per Share (A: Dec. 2016 ) |
=(-0.523-1.277)/ | 1.277 |
=-140.96 %

Kindred Healthcare's YoY EBITDA Growth for the quarter that ended in Mar. 2018 is calculated as:

YoY EBITDA Growth (Q: Mar. 2018 )
=(EBITDA per Share (Q: Mar. 2018 )-EBITDA per Share (Q: Mar. 2017 )) / | EBITDA per Share (Q: Mar. 2017 )) |
=(1.28-1.168)/ | 1.168 |
=9.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kindred Healthcare YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Kindred Healthcare's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindred Healthcare (Kindred Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
Kindred Healthcare Inc is a healthcare-services company in the United States that operates in four divisions: hospitals, Kindred at Home, Kindred Rehabilitation Services, and nursing centers. The hospital division provides long-term acute-care services through a network of transitional-care hospitals. The Kindred at Home division provides home health and hospice care for patients in their homes, nursing centers, and other residential settings. This segment contributes the majority of the firm's total revenue. The Rehabilitation Services division provides physical and occupational therapy to residents of nursing centers, hospitals, outpatient clinics, and assisted living facilities. Kindred's nursing center division operates nursing centers and assisted-care facilities.
Executives
Heyward R Donigan director 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451
Phyllis R Yale director
Paul J Diaz director 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202
Joel Ackerman director COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR SUITE 900, BETHESDA MD 20817
Richard Goodman director PEPSICO, INC., 700 ANDERSON HILL ROAD, PURCHASE NY 10577
Christopher T Hjelm director C/O THE KROGER CO., 1014 VINE ST., CINCINNATI OH 45202
Stephen D Farber officer: EVP & Chief Financial Officer 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202
Jonathan David Blum director C/O YUM BRANDS INC, 1441 GARDINER LANE, LOUISVILLE KY 40213
Lynn T Simon director 4000 MERIDIAN BOULEVARD, FRANKLIN TN 37067
Fred J Kleisner director C/O MORGANS HOTEL GROUP CO., 475 TENTH AVENUE, NEW YORK NY 10018
Sharad Mansukani director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Thomas P Cooper director PO BOX 3335, SANTA FE CA 92067
John H Short director 7733 FORSYTH BLVD.,, SUITE 2300, ST. LOUIS MO 63105
Edward L Kuntz director, other: Chairman of the Board
Richard A Lechleiter officer: Executive VP and CFO PO BOX 32890, LOUISVILLE KY 40232-2890